Atlas Trials

S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic Cancer

Clinical trial NCT03316326 · UNKNOWN

Trial details

NCT number
NCT03316326
Sponsor
National Taiwan University Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Ductal Adenocarcinoma
Start date
2017-11-01
Primary completion
2021-12-31
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.